{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:16:06Z","timestamp":1772172966654,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1009418","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000}}],"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Increasing body of experimental evidence suggests that anticancer and antimicrobial therapies may themselves promote the acquisition of drug resistance by increasing mutability. The successful control of evolving populations requires that such biological costs of control are identified, quantified and included to the evolutionarily informed treatment protocol. Here we identify, characterise and exploit a trade-off between decreasing the target population size and generating a surplus of treatment-induced rescue mutations. We show that the probability of cure is maximized at an intermediate dosage, below the drug concentration yielding maximal population decay, suggesting that treatment outcomes may in some cases be substantially improved by less aggressive treatment strategies. We also provide a general analytical relationship that implicitly links growth rate, pharmacodynamics and dose-dependent mutation rate to an optimal control law. Our results highlight the important, but often neglected, role of fundamental eco-evolutionary costs of control. These costs can often lead to situations, where decreasing the cumulative drug dosage may be preferable even when the objective of the treatment is elimination, and not containment. Taken together, our results thus add to the ongoing criticism of the standard practice of administering aggressive, high-dose therapies and motivate further experimental and clinical investigation of the mutagenicity and other hidden collateral costs of therapies.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1009418","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T10:36:37Z","timestamp":1632479797000},"page":"e1009418","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Drug-induced resistance evolution necessitates less aggressive treatment"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-5048","authenticated-orcid":true,"given":"Teemu","family":"Kuosmanen","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1329-2025","authenticated-orcid":true,"given":"Johannes","family":"Cairns","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8057-4252","authenticated-orcid":true,"given":"Robert","family":"Noble","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0573-6119","authenticated-orcid":true,"given":"Niko","family":"Beerenwinkel","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-0813","authenticated-orcid":true,"given":"Tommi","family":"Mononen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7270-1792","authenticated-orcid":true,"given":"Ville","family":"Mustonen","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"issue":"1610","key":"pcbi.1009418.ref001","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2012.0404","article-title":"Evolutionary rescue: An emerging focus at the intersection between ecology and evolution","volume":"368","author":"A Gonzalez","year":"2013","journal-title":"Philosophical Transactions of the Royal Society B: Biological Sciences"},{"issue":"10","key":"pcbi.1009418.ref002","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/eva.12221","article-title":"Evolutionary rescue: Linking theory for conservation and medicine","volume":"7","author":"HK Alexander","year":"2014","journal-title":"Evolutionary Applications"},{"issue":"1","key":"pcbi.1009418.ref003","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1534\/genetics.118.300908","article-title":"Evolutionary rescue over a fitness landscape","volume":"209","author":"Y Anciaux","year":"2018","journal-title":"Genetics"},{"issue":"SUPPL. 2","key":"pcbi.1009418.ref004","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1073\/pnas.1100299108","article-title":"The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy","volume":"108","author":"AF Read","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"pcbi.1009418.ref005","first-page":"3643","article-title":"The Genetic Origin of Drug Resistance in Neoplasms: Implications for Systemic Therapy","volume":"44","author":"JH Goldie","year":"1984","journal-title":"Cancer Research"},{"key":"pcbi.1009418.ref006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semcancer.2015.09.002","article-title":"Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine","volume":"35","author":"S Benzekry","year":"2015","journal-title":"Seminars in Cancer Biology"},{"issue":"3","key":"pcbi.1009418.ref007","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tim.2015.01.005","article-title":"Is selection relevant in the evolutionary emergence of drug resistance?","volume":"23","author":"T Day","year":"2015","journal-title":"Trends in Microbiology"},{"issue":"2","key":"pcbi.1009418.ref008","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0025-5564(92)90038-X","article-title":"Optimal control of tumor size used to maximize survival time when cells are resistant to chemotherapy","volume":"110","author":"RB Martin","year":"1992","journal-title":"Mathematical Biosciences"},{"issue":"11","key":"pcbi.1009418.ref009","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-08-3658","article-title":"Adaptive therapy","volume":"69","author":"RA Gatenby","year":"2009","journal-title":"Cancer Research"},{"issue":"2","key":"pcbi.1009418.ref010","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jtbi.2008.12.006","article-title":"Modelling chemotherapy resistance in palliation and failed cure","volume":"257","author":"HC Monro","year":"2009","journal-title":"Journal of Theoretical Biology"},{"issue":"2","key":"pcbi.1009418.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.2001110","article-title":"How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient","volume":"15","author":"E Hansen","year":"2017","journal-title":"PLoS Biology"},{"issue":"10","key":"pcbi.1009418.ref012","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.tim.2019.06.004","article-title":"Bystander Selection for Antimicrobial Resistance: Implications for Patient Health","volume":"27","author":"VJ Morley","year":"2019","journal-title":"Trends in Microbiology"},{"issue":"6","key":"pcbi.1009418.ref013","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/genetics\/28.6.491","article-title":"Mutations of Bacteria from Virus Sensitivity to Virus Resistance","volume":"28","author":"SE Luria","year":"1943","journal-title":"Genetics"},{"issue":"4","key":"pcbi.1009418.ref014","doi-asserted-by":"crossref","first-page":"e1007995","DOI":"10.1371\/journal.pgen.1007995","article-title":"What is mutation? A chapter in the series: How microbes \u201cjeopardize\u201d the modern synthesis","volume":"15","author":"DM Fitzgerald","year":"2019","journal-title":"PLoS genetics"},{"issue":"18","key":"pcbi.1009418.ref015","doi-asserted-by":"crossref","first-page":"E2498","DOI":"10.1073\/pnas.1601208113","article-title":"Antibiotic treatment enhances the genome-wide mutation rate of target cells","volume":"113","author":"H Long","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"December","key":"pcbi.1009418.ref016","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1126\/science.aav4474","article-title":"Adaptive mutability of colorectal cancers in response to targeted therapies","volume":"366","author":"M Russo","year":"2019","journal-title":"Science"},{"issue":"6495","key":"pcbi.1009418.ref017","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1126\/science.aau8768","article-title":"MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer","volume":"368","author":"A Cipponi","year":"2020","journal-title":"Science (New York, NY)"},{"issue":"3","key":"pcbi.1009418.ref018","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molcel.2010.01.003","article-title":"Sublethal Antibiotic Treatment Leads to Multidrug Resistance via Radical-Induced Mutagenesis","volume":"37","author":"MA Kohanski","year":"2010","journal-title":"Molecular Cell"},{"issue":"8","key":"pcbi.1009418.ref019","doi-asserted-by":"crossref","first-page":"e2002731","DOI":"10.1371\/journal.pbio.2002731","article-title":"Spontaneous mutation rate is a plastic trait associated with population density across domains of life","volume":"15","author":"R Kra\u0161ovec","year":"2017","journal-title":"PLoS biology"},{"issue":"12","key":"pcbi.1009418.ref020","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/s41588-019-0525-5","article-title":"The mutational footprints of cancer therapies","volume":"51","author":"O Pich","year":"2019","journal-title":"Nature Genetics"},{"key":"pcbi.1009418.ref021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms3467","article-title":"Non-Darwinian dynamics in therapy-induced cancer drug resistance","volume":"4","author":"AO Pisco","year":"2013","journal-title":"Nature Communications"},{"issue":"12","key":"pcbi.1009418.ref022","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrc3606","article-title":"Life history trade-offs in cancer evolution","volume":"13","author":"CA Aktipis","year":"2013","journal-title":"Nature Reviews Cancer"},{"issue":"7","key":"pcbi.1009418.ref023","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41579-019-0196-3","article-title":"Definitions and guidelines for research on antibiotic persistence","volume":"17","author":"NQ Balaban","year":"2019","journal-title":"Nature Reviews Microbiology"},{"issue":"1","key":"pcbi.1009418.ref024","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","article-title":"The great escape: tumour cell plasticity in resistance to targeted therapy","volume":"19","author":"S Boumahdi","year":"2020","journal-title":"Nature Reviews Drug Discovery"},{"key":"pcbi.1009418.ref025","article-title":"Trade-offs between drug toxicity and benefit in the multi-antibiotic resistance system underlie optimal growth of E. coli","volume":"6","author":"KB Wood","year":"2012","journal-title":"BMC Systems Biology"},{"issue":"January","key":"pcbi.1009418.ref026","first-page":"1","article-title":"Stochastic expression of a multiple antibiotic resistance activator confers transient resistance in single cells","volume":"6","author":"I El Meouche","year":"2016","journal-title":"Scientific Reports"},{"issue":"6415","key":"pcbi.1009418.ref027","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1126\/science.aar7981","article-title":"Heterogeneity in efflux pump expression predisposes antibiotic-resistant cells to mutation","volume":"362","author":"I El Meouche","year":"2018","journal-title":"Science"},{"key":"pcbi.1009418.ref028","doi-asserted-by":"crossref","unstructured":"Maltas J, Wood KB. Pervasive and diverse collateral sensitivity profiles inform optimal strategies to limit antibiotic resistance. vol. 17; 2019.","DOI":"10.1371\/journal.pbio.3000515"},{"issue":"39","key":"pcbi.1009418.ref029","doi-asserted-by":"crossref","first-page":"9767","DOI":"10.1073\/pnas.1810004115","article-title":"Cellular hysteresis as a principle to maximize the efficacy of antibiotic therapy","volume":"115","author":"R Roemhild","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"pcbi.1009418.ref030","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.44.7.1771-1777.2000","article-title":"Mutation frequencies and antibiotic resistance","volume":"44","author":"JL Martinez","year":"2000","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"April","key":"pcbi.1009418.ref031","first-page":"1","article-title":"Drug-Induced Resistance in Micrometastases: Analysis of Spatio-Temporal Cell Lineages","volume":"11","author":"J P\u00e9rez-Vel\u00e1zquez","year":"2020","journal-title":"Frontiers in Physiology"},{"issue":"33","key":"pcbi.1009418.ref032","doi-asserted-by":"crossref","first-page":"19694","DOI":"10.1073\/pnas.1920263117","article-title":"Eco-evolutionary control of pathogens","volume":"117","author":"M L\u00e4ssig","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"pcbi.1009418.ref033","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"JMA Blair","year":"2015","journal-title":"Nature Reviews Microbiology"},{"issue":"1","key":"pcbi.1009418.ref034","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3934\/dcdsb.2006.6.129","article-title":"Drug resistance in cancer chemotherapy as an optimal control problem","volume":"6","author":"U Ledzewicz","year":"2006","journal-title":"Discrete and Continuous Dynamical Systems\u2014Series B"},{"issue":"5","key":"pcbi.1009418.ref035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.3000713","article-title":"Antibiotics can be used to contain drug-resistant bacteria by maintaining sufficiently large sensitive populations","volume":"18","author":"E Hansen","year":"2020","journal-title":"PLoS Biology"},{"key":"pcbi.1009418.ref036","doi-asserted-by":"crossref","unstructured":"Lenhart S, Workman JT. Optimal Control Applied to Biological Models; 2007.","DOI":"10.1201\/9781420011418"},{"issue":"11","key":"pcbi.1009418.ref037","first-page":"1","article-title":"Dose-dependent mutation rates determine optimum erlotinib dosing strategies for EGFR mutant non-small cell lung cancer patients","volume":"10","author":"LL Liu","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"pcbi.1009418.ref038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.18.00087","article-title":"Mathematical Approach to Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment","author":"JM Greene","year":"2019","journal-title":"JCO Clinical Cancer Informatics"},{"key":"pcbi.1009418.ref039","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00501","article-title":"Mathematical details on a cancer resistance model","volume":"8","author":"JM Greene","year":"2020","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"32","key":"pcbi.1009418.ref040","doi-asserted-by":"crossref","first-page":"19455","DOI":"10.1073\/pnas.1919672117","article-title":"Stochastic bacterial population dynamics restrict the establishment of antibiotic resistance from single cells","volume":"117","author":"HK Alexander","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"pcbi.1009418.ref041","first-page":"1","article-title":"Bet Hedging against Demographic Fluctuations","volume":"119","author":"B Xue","year":"2017","journal-title":"Physical Review Letters"},{"key":"pcbi.1009418.ref042","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15589","article-title":"Time-programmable drug dosing allows the manipulation, suppression and reversal of antibiotic drug resistance in vitro","volume":"8","author":"M Yoshida","year":"2017","journal-title":"Nature Communications"},{"issue":"2","key":"pcbi.1009418.ref043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1103\/PhysRevE.99.022404","article-title":"Nonlinear adaptive control of competitive release and chemotherapeutic resistance","volume":"99","author":"PK Newton","year":"2019","journal-title":"Physical Review E"},{"issue":"4","key":"pcbi.1009418.ref044","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1073\/pnas.1409403112","article-title":"The value of monitoring to control evolving populations","volume":"112","author":"A Fischer","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"pcbi.1009418.ref045","doi-asserted-by":"crossref","unstructured":"Vasse M, Bonhoeffer S, Frenoy A. Ecological effects of stress drive bacterial evolvability under sub-inhibitory antibiotic treatments. bioRxiv. 2020; https:\/\/doi.org\/10.1101\/2020.06.30.181099.","DOI":"10.1101\/2020.06.30.181099"},{"issue":"327","key":"pcbi.1009418.ref046","article-title":"Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer","volume":"8","author":"PM Enriquez-Navas","year":"2016","journal-title":"Science Translational Medicine"},{"issue":"1","key":"pcbi.1009418.ref047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01968-5","article-title":"Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer","volume":"8","author":"J Zhang","year":"2017","journal-title":"Nature Communications"},{"issue":"7","key":"pcbi.1009418.ref048","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/eva.12994","article-title":"Cancer therapy: Attempt cure or manage drug resistance?","volume":"13","author":"E Hansen","year":"2020","journal-title":"Evolutionary Applications"},{"issue":"7","key":"pcbi.1009418.ref049","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41396-019-0392-1","article-title":"Modelling microbiome recovery after antibiotics using a stability landscape framework","volume":"13","author":"LP Shaw","year":"2019","journal-title":"ISME Journal"},{"issue":"1","key":"pcbi.1009418.ref050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-019-0533-3","article-title":"Antibiotics versus biofilm: An emerging battleground in microbial communities","volume":"8","author":"D Sharma","year":"2019","journal-title":"Antimicrobial Resistance and Infection Control"},{"issue":"18","key":"pcbi.1009418.ref051","doi-asserted-by":"crossref","first-page":"9253","DOI":"10.1128\/JVI.76.18.9253-9259.2002","article-title":"Combination of Drugs and Drug-Resistant Reverse Transcriptase Results in a Multiplicative Increase of Human Immunodeficiency Virus Type 1 Mutant Frequencies","volume":"76","author":"LM Mansky","year":"2002","journal-title":"Journal of Virology"},{"issue":"5","key":"pcbi.1009418.ref052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.2005056","article-title":"Death and population dynamics affect mutation rate estimates and evolvability under stress in bacteria","volume":"16","author":"A Frenoy","year":"2018","journal-title":"PLoS Biology"},{"issue":"November 2020","key":"pcbi.1009418.ref053","article-title":"Somatic mutation landscapes at single-molecule resolution","volume":"593","author":"F Abascal","year":"2021","journal-title":"Nature"},{"issue":"11","key":"pcbi.1009418.ref054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1007493","article-title":"Contrasting the impact of cytotoxic and cytostatic drug therapies on tumour progression","volume":"15","author":"JV Anttila","year":"2019","journal-title":"PLoS Computational Biology"},{"key":"pcbi.1009418.ref055","volume-title":"Stochastic optimal control: theory and application","author":"RF Stengel","year":"1986"},{"key":"pcbi.1009418.ref056","article-title":"Emergent multicellular life cycles in filamentous bacteria owing to density-dependent population dynamics","author":"V Rossetti","year":"2011","journal-title":"Journal of the Royal Society Interface"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1009418","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T01:12:29Z","timestamp":1633482749000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009418"}},"subtitle":[],"editor":[{"given":"Mark M.","family":"Tanaka","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1009418","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.07.330134","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]}}}